Alkeus Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.alkeuspharma.com
Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
Phase 2
Active, not recruiting
- Conditions
- Stargardt Macular DystrophyAutosomal Recessive Stargardt Disease 1 (ABCA4-related)Stargardt DiseaseStargardt Macular Degeneration
- Interventions
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Alkeus Pharmaceuticals, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT04239625
- Locations
- 🇺🇸
Alkeus Site, Silverdale, Washington, United States
Phase 3 Study of ALK-001 in Geographic Atrophy
Phase 3
Completed
- Conditions
- Age Related Macular DegenerationGeographic AtrophyAtrophy, GeographicAMD
- Interventions
- Drug: Placebo oral capsuleDrug: ALK-001 oral capsule
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Alkeus Pharmaceuticals, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT03845582
- Locations
- 🇺🇸
Coordinating Center, Somerville, Massachusetts, United States
Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
Phase 2
- Conditions
- Stargardt Macular DystrophyAutosomal Recessive Stargardt Disease 1 (ABCA4-related)Stargardt DiseaseStargardt Macular Degeneration
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-03-30
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Alkeus Pharmaceuticals, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT02402660
- Locations
- 🇺🇸
Alkeus Site, Milwaukee, Wisconsin, United States
Phase 1 Safety Study of ALK-001 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Stargardt DiseaseAge-related Macular DegenerationOther Retinal Dystrophies
- Interventions
- Drug: ALK-001 (No generic name)
- First Posted Date
- 2014-09-03
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Alkeus Pharmaceuticals, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02230228
© Copyright 2025. All Rights Reserved by MedPath